Article
Immune checkpoint-related gene polymorphisms are associated with acute myeloid leukemia.
Cancer medicine - 1 Sept 2023
Wu Yuyan, Li Mingying, Meng Guangqiang, Ma Yuechan, Ye Jingjing, Sun Tao, Ji Chunyan
Abstract excerpt
BACKGROUND: Chemotherapy is still the standard regimen for treating acute myeloid leukemia (AML) and its disappointing efficacy requires the urgent need for new therapeutic targets. It is well known that immune response plays an increasingly significant role in the pathogenesis of AML. METHODS: We detected nine single nucleotide polymorphisms (SNPs) in immune checkpoint-related genes, including PD1, LAG3, TIM3,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
